Cynthia Schaeffer

2.2k total citations
3 papers, 351 citations indexed

About

Cynthia Schaeffer is a scholar working on Oncology, Biotechnology and Organic Chemistry. According to data from OpenAlex, Cynthia Schaeffer has authored 3 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Oncology, 2 papers in Biotechnology and 1 paper in Organic Chemistry. Recurrent topics in Cynthia Schaeffer's work include Cancer Research and Treatments (2 papers), Click Chemistry and Applications (1 paper) and Cancer-related Molecular Pathways (1 paper). Cynthia Schaeffer is often cited by papers focused on Cancer Research and Treatments (2 papers), Click Chemistry and Applications (1 paper) and Cancer-related Molecular Pathways (1 paper). Cynthia Schaeffer collaborates with scholars based in United States. Cynthia Schaeffer's co-authors include Daniel Quirk, Shelby Sullivan, Charles F. Barish, Felix Tiongco, Raj Bhandari, Taddese Desta, Michael DeMicco, Brooks D. Cash, K. Peter Etzkorn and David Bernstein and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Gastrointestinal Endoscopy.

In The Last Decade

Cynthia Schaeffer

3 papers receiving 341 citations

Peers

Cynthia Schaeffer
Mengmeng Dong China
Nikhil Tiwari India
Kevin Berardino United States
Julia Werner Germany
Yanping Song China
Takanori Yano Japan
Tilo Schorn Italy
Gladys G. Lawrence United States
Yuhui Cui China
Mengmeng Dong China
Cynthia Schaeffer
Citations per year, relative to Cynthia Schaeffer Cynthia Schaeffer (= 1×) peers Mengmeng Dong

Countries citing papers authored by Cynthia Schaeffer

Since Specialization
Citations

This map shows the geographic impact of Cynthia Schaeffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cynthia Schaeffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cynthia Schaeffer more than expected).

Fields of papers citing papers by Cynthia Schaeffer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cynthia Schaeffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cynthia Schaeffer. The network helps show where Cynthia Schaeffer may publish in the future.

Co-authorship network of co-authors of Cynthia Schaeffer

This figure shows the co-authorship network connecting the top 25 collaborators of Cynthia Schaeffer. A scholar is included among the top collaborators of Cynthia Schaeffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cynthia Schaeffer. Cynthia Schaeffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

3 of 3 papers shown
1.
Rex, Douglas K., Raj Bhandari, Taddese Desta, et al.. (2018). A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointestinal Endoscopy. 88(3). 427–437.e6. 196 indexed citations
2.
Warso, Michael, Jon Richards, Konstantin Christov, et al.. (2013). A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours. British Journal of Cancer. 108(5). 1061–1070. 146 indexed citations
3.
Richards, Jon, Michael Warso, Konstantin Christov, et al.. (2011). A first-in-class, first-in-human phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with metastatic refractory solid tumors.. Journal of Clinical Oncology. 29(15_suppl). 2511–2511. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mengmeng Dong Breakdown of academic impact, for papers by Nikhil Tiwari Breakdown of academic impact, for papers by Kevin Berardino Breakdown of academic impact, for papers by Julia Werner Breakdown of academic impact, for papers by Yanping Song Breakdown of academic impact, for papers by Takanori Yano Breakdown of academic impact, for papers by Tilo Schorn Breakdown of academic impact, for papers by Gladys G. Lawrence Breakdown of academic impact, for papers by Yuhui Cui
Rankless by CCL
2026